Status:

COMPLETED

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

Lead Sponsor:

Stanford University

Conditions:

Kidney Transplant

Diabetes Mellitus, Type 2

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

Protocol Title: Randomized open label study comparing the metabolic control of first Kidney Transplant recipients with Type 2 Diabetes Mellitus (DM) receiving either Prograf or Neoral as part of a ATG...

Detailed Description

It has been accepted that patients with DM are associated with a greater risk of morbidity and mortality and hyperlipidemia, compromised graft function, stroke, nephropathy, atherosclerotic cardiovasc...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Inclusion Criteria
  • Patient is a recipient of a first cadaveric kidney, or a kidney living donor mismatched (at least one mismatch.)
  • Patient is a minimum of 18 years of age at the time of transplant.
  • Patient has type 2 non-insulin dependent diabetes.
  • Patient or legal guardian has signed and dated an Ethics Committee-approved informed consent document and is willing and able to follow study procedures.
  • If female and is childbearing potential, patient has a negative pregnancy test and utilizes adequate contraceptive methods.
  • Exclusion Criteria
  • Recipients of a transplant graft from a donor age 65 and older.
  • Recipient of a multi-organ transplant.
  • Patients who are being re-transplanted will not be eligible for study.
  • Patients who have lost a previous graft to rejection less than one year from transplant.
  • Patient has any form of substance abuse, psychiatric disorder, or a condition in the opinion of the investigator, may invalidate communication with the investigator.
  • PRA \> 30%

Exclusion

    Key Trial Info

    Start Date :

    June 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2014

    Estimated Enrollment :

    29 Patients enrolled

    Trial Details

    Trial ID

    NCT00296296

    Start Date

    June 1 2005

    End Date

    October 1 2014

    Last Update

    October 6 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Stanford university Hospital and Clinics

    Stanford, California, United States, 94305